FDAnews Drug Daily Bulletin

BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE

May 5, 2006
A A

Biogen Idec and Conforma Therapeutics Corporation, a privately held biopharmaceutical company focused on the design and development of novel drugs for the treatment of cancer, recently announced that they have signed a definitive merger agreement for the acquisition of Conforma by Biogen Idec.
Financial News USA